245 related articles for article (PubMed ID: 22531947)
1. Specific bile acids inhibit hepatic fatty acid uptake in mice.
Nie B; Park HM; Kazantzis M; Lin M; Henkin A; Ng S; Song S; Chen Y; Tran H; Lai R; Her C; Maher JJ; Forman BM; Stahl A
Hepatology; 2012 Oct; 56(4):1300-10. PubMed ID: 22531947
[TBL] [Abstract][Full Text] [Related]
2. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis.
Doege H; Baillie RA; Ortegon AM; Tsang B; Wu Q; Punreddy S; Hirsch D; Watson N; Gimeno RE; Stahl A
Gastroenterology; 2006 Apr; 130(4):1245-58. PubMed ID: 16618416
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL
Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483
[TBL] [Abstract][Full Text] [Related]
4. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.
Ljubuncic P; Fuhrman B; Oiknine J; Aviram M; Bomzon A
Gut; 1996 Sep; 39(3):475-8. PubMed ID: 8949657
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
[TBL] [Abstract][Full Text] [Related]
7. ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).
Ason B; Castro-Perez J; Tep S; Stefanni A; Tadin-Strapps M; Roddy T; Hankemeier T; Hubbard B; Sachs AB; Michael Flanagan W; Kuklin NA; Mitnaul LJ
Lipids; 2011 Nov; 46(11):991-1003. PubMed ID: 21826528
[TBL] [Abstract][Full Text] [Related]
8. New highly toxic bile acids derived from deoxycholic acid, chenodeoxycholic acid and lithocholic acid.
Májer F; Sharma R; Mullins C; Keogh L; Phipps S; Duggan S; Kelleher D; Keely S; Long A; Radics G; Wang J; Gilmer JF
Bioorg Med Chem; 2014 Jan; 22(1):256-68. PubMed ID: 24332653
[TBL] [Abstract][Full Text] [Related]
9. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation.
Mooranian A; Zamani N; Ionescu CM; Takechi R; Luna G; Mikov M; Goločorbin-Kon S; Kovačević B; Al-Salami H
Pharmacol Rep; 2020 Apr; 72(2):368-378. PubMed ID: 32048259
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes.
Kubaska WM; Gurley EC; Hylemon PB; Heuman DM; Mosbach EH; Vlahcevic ZR
Biochim Biophys Acta; 1987 Aug; 920(3):195-204. PubMed ID: 3607077
[TBL] [Abstract][Full Text] [Related]
12. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism.
Kumari A; Pal Pathak D; Asthana S
Int J Biol Sci; 2020; 16(13):2308-2322. PubMed ID: 32760200
[TBL] [Abstract][Full Text] [Related]
13. Effects of bile acids on iodide uptake and deoxyribonucleic acid synthesis in porcine thyroid cells in primary culture.
Kanri R; Takiyama Y; Makino I
Thyroid; 1996 Oct; 6(5):467-74. PubMed ID: 8936674
[TBL] [Abstract][Full Text] [Related]
14. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
16. Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity.
Powell AA; Akare S; Qi W; Herzer P; Jean-Louis S; Feldman RA; Martinez JD
BMC Cancer; 2006 Sep; 6():219. PubMed ID: 16948850
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture.
Martinez-Diez MC; Serrano MA; Monte MJ; Marin JJ
Biochim Biophys Acta; 2000 Feb; 1500(2):153-60. PubMed ID: 10657584
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP [correction of CXP] and preservation of BSEP activities.
Paolini M; Pozzetti L; Montagnani M; Potenza G; Sabatini L; Antelli A; Cantelli-Forti G; Roda A
Hepatology; 2002 Aug; 36(2):305-14. PubMed ID: 12143038
[TBL] [Abstract][Full Text] [Related]
19. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
[TBL] [Abstract][Full Text] [Related]
20. Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity.
Hubbard B; Doege H; Punreddy S; Wu H; Huang X; Kaushik VK; Mozell RL; Byrnes JJ; Stricker-Krongrad A; Chou CJ; Tartaglia LA; Lodish HF; Stahl A; Gimeno RE
Gastroenterology; 2006 Apr; 130(4):1259-69. PubMed ID: 16618417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]